RU94011565A - THIOXANTENONE COMPOUNDS, THEIR USE, ANTI-SMALL COMPOSITION - Google Patents

THIOXANTENONE COMPOUNDS, THEIR USE, ANTI-SMALL COMPOSITION

Info

Publication number
RU94011565A
RU94011565A RU94011565/04A RU94011565A RU94011565A RU 94011565 A RU94011565 A RU 94011565A RU 94011565/04 A RU94011565/04 A RU 94011565/04A RU 94011565 A RU94011565 A RU 94011565A RU 94011565 A RU94011565 A RU 94011565A
Authority
RU
Russia
Prior art keywords
lower alkyl
hydroxyl
hydrogen
thioxantenone
compounds
Prior art date
Application number
RU94011565/04A
Other languages
Russian (ru)
Other versions
RU2138495C1 (en
Inventor
Филип Вентленд Марк
Бруно Перни Роберт
Зилльм Гайлс Джозеф
Original Assignee
Стерлинг Уинтроп Инк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/044,843 external-priority patent/US5346917A/en
Application filed by Стерлинг Уинтроп Инк filed Critical Стерлинг Уинтроп Инк
Publication of RU94011565A publication Critical patent/RU94011565A/en
Application granted granted Critical
Publication of RU2138495C1 publication Critical patent/RU2138495C1/en

Links

Claims (1)

Патентуются соединения, обладающие противоопухолевой активностью, строения:
Figure 00000001

где (1) n равно 2 или 3; R1 и R2 - независимо друг от друга низший алкил; Q - остаток, выбранный из группы, состоящей из CH2NHR3, CH2N(R4)SO2R7, CH2NHCHO, CH = N - AR, C(O)NR5R6, CH2N(P4)C(O)R7, CH2N(C2H5)CHO, CH2N(R4)P(O)(O-низший алкил)2, CH2N = CH - N(R9)(R10),
CH2N(R4)C(O)CF3 и CH2N(R4)C(O)OR7; R3 - водород или низший алкил; R4 - водород, низший алкил или Ar; R5 - водород или низший алкил; R7 - низший алкил или Ar; R8 - гидроксил; Ar - фенил или фенил, замещенный метилом, метокси, гидроксилом, галоидом или нитрогруппой; и R9 и R10 - независимо друг от друга, низший алкил; (2) Q - остаток, выбранный из группы, состоящей из CHN(R4)SO2R7, CH =N-AR, C(O)NR5R6, CH2N(R4)C(O)R7, CH2N(R4)P(O) (O-низший алкил)2, CH2N(R4)C(O)CF3 и CH2N(R4)C(O)OR7; R8 - водород, низший алкил, низший алкокси или гидроксил; Ar - фенил, замещенный гидроксилом и n, R1, R2, R4, R5, R6 и R7 принимают значения, определенные в части (1), при условии, что один или более из R4, R5 или R7 - Ar; или (3) Q - остаток, выбранный из группы, состоящей из CH2N= CHN(R9)(R10), CH2N(R4)C(O)CF3 и CH2N(R4)C(O)OR7; R8 - водород, низший алкил, низший алкокси или гидроксил; и n, R1, R2, R4, R7, Ar, R9 и R10 принимают значения, определенные в части (1), или их фармацевтически приемлемые кислотно-аддитивные соли или сольваты. Патентуются также композиции, содержащие тиоксантеноны, и методы лечения опухолей и заболеваний рака у млекопитающих с использованием тиоксантенонов.
Patented compounds with antitumor activity, structure:
Figure 00000001

where (1) n is 2 or 3; R 1 and R 2 are independently lower alkyl; Q is a residue selected from the group consisting of CH 2 NHR 3 , CH 2 N (R 4 ) SO 2 R 7 , CH 2 NHCHO, CH = N - AR, C (O) NR 5 R 6 , CH 2 N ( P 4 ) C (O) R 7 , CH 2 N (C 2 H 5 ) CHO, CH 2 N (R 4 ) P (O) (O-lower alkyl) 2 , CH 2 N = CH - N (R 9 ) (R 1 0 ),
CH 2 N (R 4 ) C (O) CF 3 and CH 2 N (R 4 ) C (O) OR 7 ; R 3 is hydrogen or lower alkyl; R 4 is hydrogen, lower alkyl or Ar; R 5 is hydrogen or lower alkyl; R 7 is lower alkyl or Ar; R 8 is hydroxyl; Ar is phenyl or phenyl substituted by methyl, methoxy, hydroxyl, halogen or nitro; and R 9 and R 1 0 - independently of each other, lower alkyl; (2) Q is a residue selected from the group consisting of CHN (R 4 ) SO 2 R 7 , CH = N-AR, C (O) NR 5 R 6 , CH 2 N (R 4 ) C (O) R 7 , CH 2 N (R 4 ) P (O) (O-lower alkyl) 2 , CH 2 N (R 4 ) C (O) CF 3 and CH 2 N (R 4 ) C (O) OR 7 ; R 8 is hydrogen, lower alkyl, lower alkoxy or hydroxyl; Ar is phenyl substituted by hydroxyl and n, R 1 , R 2 , R 4 , R 5 , R 6 and R 7 take the values defined in part (1), provided that one or more of R 4 , R 5 or R 7 - Ar; or (3) Q is a residue selected from the group consisting of CH 2 N = CHN (R 9 ) (R 1 0 ), CH 2 N (R 4 ) C (O) CF 3 and CH 2 N (R 4 ) C (O) OR 7 ; R 8 is hydrogen, lower alkyl, lower alkoxy or hydroxyl; and n, R 1 , R 2 , R 4 , R 7 , Ar, R 9 and R 1 0 are as defined in paragraph (1), or their pharmaceutically acceptable acid addition salts or solvates. Thioxantenone-containing compositions and methods for treating tumors and cancer diseases in mammals using thioxantenones are also patented.
RU94011565A 1993-04-08 1994-04-07 Thioxanthenone compounds and pharmaceutical compositions showing antitumor activity RU2138495C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US044843 1993-04-08
US08/044,843 US5346917A (en) 1991-06-10 1993-04-08 Thioxanthenone antitumor agents

Publications (2)

Publication Number Publication Date
RU94011565A true RU94011565A (en) 1996-01-27
RU2138495C1 RU2138495C1 (en) 1999-09-27

Family

ID=21934632

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94011565A RU2138495C1 (en) 1993-04-08 1994-04-07 Thioxanthenone compounds and pharmaceutical compositions showing antitumor activity

Country Status (24)

Country Link
US (2) US5346917A (en)
EP (3) EP1197491B1 (en)
JP (1) JPH06340655A (en)
KR (1) KR100344136B1 (en)
AT (3) ATE221524T1 (en)
AU (1) AU679717B2 (en)
CA (1) CA2120782C (en)
CZ (1) CZ289473B6 (en)
DE (3) DE69431131T2 (en)
DK (3) DK0882723T3 (en)
ES (3) ES2180100T3 (en)
FI (2) FI941638A (en)
GR (1) GR3030949T3 (en)
HU (1) HUT67899A (en)
IL (1) IL109241A (en)
MY (1) MY131770A (en)
NO (1) NO306947B1 (en)
NZ (1) NZ260255A (en)
PT (2) PT882723E (en)
RU (1) RU2138495C1 (en)
SG (1) SG52765A1 (en)
SK (1) SK283799B6 (en)
TW (1) TW242623B (en)
UA (1) UA41281C2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665760A (en) * 1995-09-18 1997-09-09 Sanofi Winthrop, Inc. Lyophilized thioxanthenone antitumor agents
US7126011B2 (en) * 2000-11-15 2006-10-24 Prom Limited Process for the preparation of thioxanthones
GB0115893D0 (en) * 2001-06-28 2001-08-22 Sanofi Synthelabo Formulations
US6747039B2 (en) * 2002-03-12 2004-06-08 Albany Molecular Research, Inc. Aza-benzothiopyranoindazoles with antitumor activity
US20030212061A1 (en) * 2002-03-12 2003-11-13 Haydar Simon N. Aza-thioxanthenones with antitumor activity
BR0316296A (en) * 2002-11-18 2005-12-13 Arqule Inc Lapacone compounds and their methods of use
US6767919B2 (en) * 2002-12-17 2004-07-27 Walker Cancer Research Institute, Inc. High specificity anticancer agents
US20080114055A1 (en) * 2006-11-10 2008-05-15 Zoltan Laboratories Llc Thioxanthone Compounds to Reverse Weight Loss
US20080207738A1 (en) * 2007-02-28 2008-08-28 Cancure Laboratories, Llc Drug combinations to treat drug resistant tumors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312598A (en) * 1965-06-14 1967-04-04 Sterling Drug Inc Fermentative oxidation of substituted thioxanthenes and xanthenes
US3745172A (en) * 1970-10-05 1973-07-10 Sterling Drug Inc 1-(di-(lower-alkyl)aminoalkylamino)-9-oxothioxanthenes
US4539412A (en) * 1982-07-08 1985-09-03 Rensselaer Polytechnic Institute 7-Hydroxylucanthone, 7-hydroxhycanthone and their analogs
GB8400203D0 (en) * 1984-01-05 1984-02-08 Wellcome Found Tricyclic compounds
US4582851A (en) * 1984-02-06 1986-04-15 Warner-Lambert Company Anti-bacterial 1,4-aminoalkylamino-9H-thioxanthen-9-one derivatives, compositions, and method of use therefor
US5091410A (en) * 1991-06-10 1992-02-25 Sterling Winthrop Inc. Thioxanthenone antitumor agents
AU642596B2 (en) * 1991-06-10 1993-10-21 Sanofi-Synthelabo Thioxanthenone antitumor agents

Similar Documents

Publication Publication Date Title
RU2000127751A (en) ANTI-TUMOR MEDICINE
CA2012686A1 (en) Treatment and compounds
RU2203274C2 (en) Spirocyclic inhibitors of metalloproteases
RU93053760A (en) 6,7-MODIFICATION OF PAXLITAXELES, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION, TREATMENT METHOD
EA200100766A1 (en) QUINOLIN-2-ON-SUBSTITUTED HETEROAARYNE DERIVATIVES USED AS ANTI-TUMOR AGENTS
RU2004106617A (en) ANTITUMOR ANALOGUES
RU2000128058A (en) ECTEINASCIDINES, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND METHOD FOR TREATING TUMORS
RU94011565A (en) THIOXANTENONE COMPOUNDS, THEIR USE, ANTI-SMALL COMPOSITION
KR960704536A (en) Anthracyclinone derivatives and their use in amyloidosis
RU94019411A (en) KHINUK LIDINA ETHERS, INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT
PT1197491E (en) TIOXANTENONE ANTI-TUMOR AGENTS
RU94021658A (en) MONO AND BIS-ALKYLAMINE-ANTHRACYCLINES, METHOD OF OBTAINING, PHARMACEUTICAL COMPOSITION
ES527353A0 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES FROM NITROSOUREA
ATE18761T1 (en) CARBAMOYLOXYBENZHYDROL DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS.
RU2008127495A (en) DIOXOLANE DERIVATIVES FOR CANCER TREATMENT
KR930000499A (en) Thioxanthone antitumor agent
KR940005541A (en) Substituted Benzoate Derivatives
MY111111A (en) Novel (1-phenyl-1-heterocyclyl) methanol and (1-phenyl -1-heterocyclyl) methylamine drrivatives
RU2005105329A (en) GENERAL SYNTHESIS OF MERIAPORONS
RU99108453A (en) SUBSTITUTED HETEROCYCLES AS ANTI-TUMOR AGENTS
DE68909961D1 (en) 2-aminoacetamide derivatives.
RU94011231A (en) Triple substituted derivatives of cycloalkane and method of their preparation
RU93058583A (en) NEW AMIDOALKYL AND IMIDOALKYL-PIPERASINES, METHOD FOR PRODUCING THEM, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT
RU93046637A (en) Fluorotaxols
RU92004439A (en) NITROGEN-CONTAINING TETRACYCLIC COMPOUNDS, METHOD FOR THEIR PRODUCTION, USE AND PHARMACEUTICAL COMPOSITION